Our study demonstrated that Survivin is a unique miR-34a target in Ras signaling-activated prostate cancer cells and was found to promote the anti-apoptotic pathway in prostate cancer cells harboring miR-34a (Figure 7D). The gene discussed is BIRC5; the disease is prostate cancer.